Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP236059.RAFttkRy2viCTuO9MBpi3O__DwDebueeMx8xqrsFoa5ik130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP236059.RAFttkRy2viCTuO9MBpi3O__DwDebueeMx8xqrsFoa5ik130_assertion type Assertion NP236059.RAFttkRy2viCTuO9MBpi3O__DwDebueeMx8xqrsFoa5ik130_head.
- NP236059.RAFttkRy2viCTuO9MBpi3O__DwDebueeMx8xqrsFoa5ik130_assertion wasGeneratedBy ECO_0000203 NP236059.RAFttkRy2viCTuO9MBpi3O__DwDebueeMx8xqrsFoa5ik130_provenance.
- NP236059.RAFttkRy2viCTuO9MBpi3O__DwDebueeMx8xqrsFoa5ik130_assertion wasDerivedFrom befree-20150227 NP236059.RAFttkRy2viCTuO9MBpi3O__DwDebueeMx8xqrsFoa5ik130_provenance.
- NP236059.RAFttkRy2viCTuO9MBpi3O__DwDebueeMx8xqrsFoa5ik130_assertion SIO_000772 21656078 NP236059.RAFttkRy2viCTuO9MBpi3O__DwDebueeMx8xqrsFoa5ik130_provenance.
- NP236059.RAFttkRy2viCTuO9MBpi3O__DwDebueeMx8xqrsFoa5ik130_assertion evidence source_evidence_literature NP236059.RAFttkRy2viCTuO9MBpi3O__DwDebueeMx8xqrsFoa5ik130_provenance.
- NP236059.RAFttkRy2viCTuO9MBpi3O__DwDebueeMx8xqrsFoa5ik130_assertion description "[Therefore, combined inhibition of COX-2 and 5-LO or CYP2J2 may be one way to overcome low efficacy of single inhibition of COX-2 in cancer cells.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP236059.RAFttkRy2viCTuO9MBpi3O__DwDebueeMx8xqrsFoa5ik130_provenance.